Gilead names 'k­ing­pin­s' in coun­ter­feit HIV med law­suit

Gilead is mount­ing its coun­ter­feit drug law­suit, nam­ing two “king­pins” and a com­plex net­work of con­spir­a­tors who al­leged­ly sold im­i­ta­tion bot­tles of its HIV meds, some of which end­ed up in US phar­ma­cies.

The phar­ma gi­ant on Wednes­day pro­vid­ed an up­date on what it called a “large-scale, so­phis­ti­cat­ed coun­ter­feit­ing con­spir­a­cy,” ac­cus­ing two new de­fen­dants of “lead­ing and or­ches­trat­ing” a scheme to sell hun­dreds of mil­lions of dol­lars in il­le­git­i­mate drugs pos­ing as meds such as Bik­tarvy and De­scovy.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.